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ABSTRACT

Effect of Gender on the Association of Single-Nucleotide Polymorphisms with Bipolar Disorder

by
Jerald Eric Mullersman

Bipolar disorder is a relatively common form of mental illness that depends strongly on genetic
inheritance for expression. The author of this study has sought to evaluate whether the gender of
subjects influences which genetic variants are associated with the disease. A portion of the cases
from a previously published study were analyzed using PLINK software and the association of
single-nucleotide polymorphisms was evaluated separately for all cases, for female subjects
alone, and for male subjects alone. The results obtained for male subjects alone reached higher
levels of statistical significance than when both genders were evaluated together or when female
subjects were evaluated alone. The most significantly scoring polymorphisms were distinctly
different for the 2 genders. In particular, a site downstream of the ion exchanger SLC24A3 and
upstream of the Rab5-interacting protein RIN2 gene on chromosome 20 (rs6046396) yielded
very high significance in men (p=3.91 X 10-9).
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CHAPTER 1
BACKGROUND AND LITERATURE REVIEW
Some Historical Perspectives on Mental Illness
Perspectives of the Ancients
Mental illness has a long history (Bennett, 2007) that begins with ancient civilizations where
the afflicted were generally viewed as being troubled by demons or evil deities. During the
Greek classical period, Hippocratic physicians developed a system of thought that attributed
differences in behavior to the influences of “humors” and made many keen observations
concerning a variety of psychiatric conditions including mania, depression, and phobias. One of
these humors, black bile (melancholia), was associated with sadness, and it is from this that we
derive the word “melancholy”. Galen and other physicians of the classical Roman era elaborated
upon these earlier Greek formulations.
The limited insights of the Greeks and Romans were, however, largely forgotten during the
long Middle Ages and superstitious fears were ascendant during that period. With the advent of
the Enlightenment, many thinkers applied observation and reason to the evaluation of the
mentally ill once again. The efforts of Enlightenment thinkers led ultimately to the foundations
of modern psychiatric thought (Bennett, 2007).
Classification of Serious Mental Illnesses
In 1899 a German psychiatrist, Emil Kraepelin, classified serious mental illnesses into two
broad categories, manic-depressive psychosis and dementia praecox (Ebert & Bär, 2010). This
division of these serious and relatively common mental illnesses into two groups is referred to as
the Kraepelinian dichotomy and has been a long-standing principle of the classification of these
disorders. The Swiss psychiatrist Eugen Bleuler refined the concept of dementia praecox and
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introduced the concept of the schizoid personality. Ultimately, this led to changes in thinking
about the nature of dementia praecox and its being renamed as schizophrenia (Ebert & Bär,
2010).
The treatment of schizophrenia and depression through the use of drug- or electric shockinduced convulsions had some limited success during the early 20th century (Payne & Prudic,
2009). Such success encouraged a more biological view of these diseases and promoted further
investigation of their causes and treatments.
The Development of Neuroscience and Psychopharmacology
The introduction of early antipsychotic medications like chlorpromazine (López-Muñoz et al.,
2005) for the treatment of schizophrenia and lithium (Shorter, 2009) for manic-depressive
disease met with reasonable success despite problems with toxicity. This led to investments by
the pharmaceutical industry (Shen, 1999) and the development of funding by research
organizations like the newly established National Institute for Mental Health (Grob, 1996) to
promote greater understanding of the biological underpinnings of normal and abnormal brain
function. Through such understanding, it was anticipated that diagnosis and treatment could be
improved significantly.

Diagnostic Criteria for Schizophrenia, Bipolar Disorder, and Related Illnesses
The classification of mental illnesses and the criteria by which they are diagnosed have
evolved over many years. A key standard in this diagnostic classification in the United States is
the Diagnostic and Statistical Manual of Mental Disorders, which has been maintained by the
American Psychiatric Association. The current, revised fourth edition of this manual is referred
to here as DSM-IV-TR (American Psychiatric Association., 2005). According to DSM-IV-TR
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schizophrenia is viewed as a psychosis, a condition that is dominated by distorted perceptions of
reality and disordered thinking. A medical practitioner arrives at a diagnosis of schizophrenia
through eliciting a history of persistence of two or more psychotic symptoms (hallucinations,
delusions, disorganized speech, gross disorganization and/or so-called negative symptoms) and
social dysfunction in the absence of other plausible medical or psychiatric explanations. In
contrast, manic-depressive illness, which has been renamed bipolar disorder and is designated as
BD here, is classified as a disorder of mood in DSM-IV-TR. There is a spectrum of conditions
related to BD, but they all involve cycling from periods of elation, agitation, or irritation to
periods of depression. The type I condition, BD-I, is the most severe and involves mania, a
condition of elation, agitation, or irritation with a greater scope and intensity of symptoms. The
type II condition, BD-II, requires that the patient suffer from hypomania, which is similar to but
less intense than mania. Cyclothymic disorder, in turn, is similar to but less severe than, BD-II.
According to the paradigm delineated by the Kraepelinian dichotomy, schizophrenia and BD
should be considered to be clearly distinct clinical entities. However, this distinction has eroded
over the years and DSM-IV-TR includes entities like schizoaffective disorder that are chimeric
categories that include features of both a psychosis and a mood disturbance. New formulations
are being considered for inclusion in DSM-V that would place BD-like illnesses and
schizophrenia-related conditions on a spectrum that are related to each. Such an approach has
some support from genetic studies (Lake & Hurwitz, 2007), and the genetic overlap between BD
and other psychiatric conditions is discussed further below.
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Prevalence and Societal Burden of Bipolar Disorder
Mental illnesses are, in general, relatively common diseases that produce considerable
disability in sufferers and have a significant deleterious impact on economies world-wide
(Organisation mondiale de la santé, 2008). Ferrari and colleagues recently completed a
systematic review of published data for the prevalence of BD (Ferrari, Baxter, & Whiteford,
2011). The average point prevalence was found to be 0.741% for the entire spectrum of bipolar
disorders. This was felt to be an underestimate of the true prevalence due to the tendency of
many sufferers to be nonresponders to survey requests. Difficulties with clinical definitions and
the varied approaches to the inclusion of less serious conditions in the counting of subjects
complicated the development of accurate estimates. They confirmed that males and females
have very similar rates of occurrence and that prevalence was quite similar throughout the world.
Fajutrao and colleagues have recently completed a systematic review of the evidence
concerning the burden of BD in Europe (Fajutrao, Locklear, Priaulx, & Heyes, 2009). They
found tremendously large costs related to unemployment, chronic medical care, and suicide
attempts. In the UK alone, they estimated the annual national cost of BD to be £4.59 billion.
Shippee and colleagues performed a comparative analysis of the impacts in the US of unipolar
depression versus BD (Shippee et al., 2011). While unipolar depression is much more common
than BD, patients with BD experienced poverty and social dysfunction at a much higher rate than
those with unipolar depression.
The relatively high prevalence of BD and its disabling effects on patients pose a challenge for
society. This motivates a continuing desire to develop a better understanding of the disease’s
etiologic factors so that better diagnostic and therapeutic modalities can be developed. Recent
studies have been directed toward examining the genetic and other factors that promote the
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expression of BD. The next sections provide a brief summary of the genetic studies of BD that
have led up to the efforts that are described here and provide a context for understanding the
significance of the strategies employed in this work and for assessing the potential impact of the
current findings on the field.
Evidence for Genetic Predilection Toward Mental Illnesses
The advances in genetics during the 20th century and the advancing appreciation of the
biological character of some mental illnesses naturally led to assessments of the inheritance of
psychiatric diseases. Early studies relied heavily upon the study of families where mental illness
seemed to recur frequently in several branches of a family tree. Studies of twins and first-degree
relatives have typically demonstrated heritability of schizophrenia and BD in the range of 60% 90% (Edvardsen et al., 2008; Kieseppä, Partonen, Haukka, Kaprio, & Lönnqvist, 2004;
Lichtenstein et al., 2009). In order to provide a suitable context for the research being reported
here, a short history of genetic approaches that have been applied to understanding the
inheritance of BD is provided.

The Search for Genes that Underlie Psychiatric Illnesses
Early Studies of X Chromosome-Linked Inheritance
Because of the relatively high frequency with which X-linked recessive traits manifest and
because of the ease with which the inheritance of these traits can be comprehended, the human X
chromosome quickly accrued a number of genetically mapped markers. Some anecdotal
observations of apparent association of certain X-linked conditions with BD led to protracted
efforts to map genetic susceptibility to BD on the X chromosome. In a report by Mendlewicz
and colleagues, they detailed efforts to evaluate linkage between the gene for glucose-6-
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phosphate dehydrogenase and BD and traced the history of such efforts back as far as 1969
(Mendlewicz, Linkowski, & Wilmotte, 1980). There followed a controversy over the next 15
years wherein various authors made claims and counterclaims of linkage between BD and
markers on the X chromosome (Baron et al., 1993; Baron, Rainer, & Risch, 1981; Baron et al.,
1987; Berrettini et al., 1990; Bocchetta, Piccardi, Martinelli, Quesada, & Del Zompo, 1999; De
Bruyn et al., 1994; Del Zompo, Bocchetta, Goldin, & Corsini, 1984; Mendelbaum et al., 1995;
Risch & Baron, 1982). This series of reports illustrates some difficulties that have persisted,
even after the development of more sophisticated technologies, with the replication of results.
This problem with replication of findings in subsequent studies likely stems from several sources
including the effects of random error, confounding, and variation in the genetic structure of
different populations (Cichon et al., 2009; Craddock & Sklar, 2009).
Development of Genome-Wide Evaluations of Genetic Susceptibility
With the advent of the polymerase chain reaction (PCR) technology, a new era of analysis
was ushered in. PCR made it possible to evaluate a large number of microsatellite markers that
could be distinguished as sequence-tagged sites with repeat lengths varying between alleles. A
large number of linkage analyses were performed, some focusing just on candidate genes or
chromosomal regions and others seeking to detect signals across the entire genome (Dick et al.,
2003; Lambert et al., 2005; Logue et al., 2009; McAuley et al., 2009; Park et al., 2004; Ross et
al., 2008; Saunders, Zhang, Copeland, Mclnnis, & Zöllner, 2009; Zandi et al., 2007). A
substantial problem with the results obtained from early linkage scans was the breadth of the
signal peaks that arose from them. The peaks were often millions of base pairs wide and
encompassed chromosomal regions that contained a large number of genes. While they were
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quite sensitive and focused attention on a set of genes, it has often been challenging to narrow
these broad regions down to the specific genetic variants that are causal.
More recently microarrays that can determine the status of hundreds of thousands of singlenucleotide polymorphisms (SNPs) have largely supplanted the determination of microsatellite
alleles. The breadth of the regions identified by linkage scans has fallen, as larger numbers of
markers have been increasingly employed. The evaluation of SNPs can support the examination
of candidate genes, chromosomal regions, or genome-wide surveys. They also permit the ready
conduct of studies with a variety of designs. Both family studies and case-control designs can be
performed. Several genome-wide association studies (GWAS) of BD have been performed in
recent years (Baum et al., 2008; Curtis et al., 2011; Hattori et al., 2009; Lee et al., 2011;
Oedegaard, Greenwood, Johansson, et al., 2010; Sklar et al., 2008; Smith et al., 2009). While
these studies have identified some interesting candidates for genes underlying BD, there have
been challenges in replicating findings between studies. This replication problem appears to
arise from several sources including population differences, small effect size of most BD genes,
and various kinds of confounding. The current status of the effort to understand the genetics of
BD has been recently reviewed (Barnett & Smoller, 2009; Byerley & Badner, 2011; Craddock &
Sklar, 2009; Gershon, Alliey-Rodriguez, & Liu, 2011; Goes, Sanders, & Potash, 2008; Hamshere
et al., 2011; Piletz, Zhang, Ranade, & Liu, 2011). Askland and colleagues have undertaken a
pathway-oriented analysis of BD GWAS research and have concluded that a major fraction of
the genes implicated in BD are related to the function of various ion channels and elements of
the synaptic transmission apparatus (Askland, Read, & Moore, 2009).
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The Challenge of Common Disease Genes with Small Individual Effects
There is now considerable evidence that BD is caused in most individuals who suffer from
this ailment by a set of relatively common genetic variations that each have a relatively small
effect size. The detection of such small-effect genes requires relatively large numbers of cases
and depends upon controlling confounding as much as possible. There is increasing evidence
that BD overlaps with a number of other psychiatric conditions in terms of genetic etiology.
While most of the documented genetic commonality has been demonstrated for BD and
schizophrenia (Carroll & Owen, 2009; Lichtenstein et al., 2009; Palo et al., 2007; Tang,
Thornton-Wells, & Askland, 2011; Wray & Goddard, 2010), there have also been indications of
shared genetic underpinnings between BD and autism (Carroll & Owen, 2009), BD and
substance abuse (Johnson, Drgon, McMahon, & Uhl, 2009), and BD and unipolar depression
(McGuffin et al., 2003). This speaks to the complexity of all these diseases and suggests that
they may share traits that are not readily apparent. For instance, while BD does not display any
gender preference in its expression overall, that does not mean that individual contributing loci,
such as some that it shares with unipolar depression (which shows a clear female propensity),
would not demonstrate a gender-specific effect in an appropriate analytical context such as
gender stratification of an association study.
Improving the Power to Perceive Genetic Variants
In order to improve the ability to detect causal genetic variants with as much sensitivity as
possible, great care must be taken in ensuring the integrity of the genotyping data, to improve the
homogeneity of the study population, and to increase the size of the sample (Anderson et al.,
2010; Iles, 2011; Rodriguez-Murillo & Greenberg, 2008).
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The Effect of Gender on the Expression of Bipolar Disorder
Although the overall prevalence of BD in both genders is comparable, epidemiologists have
sought to determine whether specific aspects of the expression of the disease vary between the
genders. Results have varied between studies and this topic is somewhat controversial. A recent
comprehensive review finds little evidence for differences in the nature of the expression of BD
in the two genders (Diflorio & Jones, 2010). However, two more recent studies both conclude,
independently of each other, that women with BD spend more time in a depressed state than men
do (Altshuler et al., 2010; Nivoli et al., 2011). This is interesting, because unipolar depression
demonstrates a female preponderance.
There has been increasing interest in epigenetic mechanisms of control of gene expression in
the brain (Meaney & Ferguson-Smith, 2010). These epigenetic mechanisms involve methylation
and hydroxymethylation of cytosine residues, primarily at CpG dinucleotides, and posttranslational modification (e.g., acetylation) of histones in the core of nucleosomes. Evidence
regarding the role of epigenetic processes in psychiatric disorders has been reviewed (Connor &
Akbarian, 2008; Tsankova, Renthal, Kumar, & Nestler, 2007). This sort of gene regulation has
also been found to play an important role in coordinating the gender-specific development of the
brain (Matsuda et al., 2011; McCarthy & Arnold, 2011; Nugent & McCarthy, 2011). Given the
role of epigenetics in both normal sexual differentiation of the brain and in psychiatric problems,
it is perhaps not surprising that epigenetics has emerged as one of the important mechanistic
paradigms for understanding how gender may impact the expression of mental health disorders
(Jessen & Auger, 2011; Mill et al., 2008).
Another type of mechanism for the control of gene expression in the brain that has received
increased attention in recent years involves the action of noncoding RNAs. For instance, the
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altered expression of microRNAs has been implicated in both schizophrenia and BD (Forero, van
der Ven, Callaerts, & Del-Favero, 2010; Miller & Wahlestedt, 2010; Moreau, Bruse, David-Rus,
Buyske, & Brzustowicz, 2011; Xu, Karayiorgou, & Gogos, 2010). Interestingly, noncoding
RNAs, as a broad category, have been implicated in the gender-dependent processes underlying
susceptibility to psychiatric disease (Qureshi & Mehler, 2010).
Given that researchers have discovered gene control processes that intersect with both the
expression of gender differences in the brain and the development of psychiatric diseases, it is
probably not surprising that genetic alterations have been found that show a gender-specific
predisposition toward mental health disorders. For instance, the Reelin gene (RELN) has been
found to have a gender-specific association with both BD (Goes et al., 2010) and schizophrenia
(Liu et al., 2010; Shifman et al., 2008). The mechanisms by which Reelin demonstrates this
gender-specific effect are being investigated. Ovadia and Shifman reported alterations in the
pattern of mRNA splicing (Ovadia & Shifman, 2011) that may explain these effects. There have
been conflicting reports regarding the role of DNA methylation on Reelin gene function (Connor
& Akbarian, 2008). Gender has also been found to modulate the effect of a variant of the
serotonin transporter gene on the expression of mania (Rucci et al., 2009).
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CHAPTER 2
RESEARCH QUESTION AND STUDY APPROACH
Statement of the Research Question Being Posed by the Current Study
Likely because of the essentially equal prevalence of BD in men and women, the role of
gender has not been evaluated in genome-wide studies of the association between BD and
genetic markers. However, as has been delineated above, there are known mechanisms by which
gender-specific control of the expression of psychiatric illnesses like BD could occur, and some
specific examples of gender-specific effects of genetic variation on the development of BD have
already been detected. The author of the current study has sought to examine explicitly whether
stratification on gender in a genome-wide association study could detect one or more genetic
variants that contribute to the expression of BD under conditions where evaluation of the same
data set without such stratification would be unable to detect the influence of such variants.

Description of the Scientific Approach Used in the Current Study
A secondary analysis of data generated for a study previously published by Smith and
colleagues (Smith et al., 2009) was performed. In order to improve the odds of detecting genetic
variants at a level that would be considered statistically significant, some new elements of study
design were adopted as compared to the study by Smith and colleagues. A genetically more
homogeneous study population was selected. Only the European-American (EA) subjects from
the data set were chosen for study and were then evaluated using principal component analysis in
order to identify and eliminate outliers with respect to ancestry. Also, only subjects with a
diagnosis of BD type I (BD-I) were considered in this study. Finally, and most germane to the
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primary hypothesis of the study, the association analysis was performed in a manner so that the
effect of gender could be determined.
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CHAPTER 3
METHODS
Data Sources
Data for Cases and Controls from a Study of Bipolar Disorder
Data from the study of Smith and colleagues (Smith et al., 2009) were obtained via the
database of Genotypes and Phenotypes (dbGaP) that is managed by the National Center for
Bioinformatics (NCBI). Per dbGaP, the use of this data set, designated phs000017.v3.p1, does
not require Institutional Review Board approval (“dbGaP | phs000017.v3.p1 | Whole Genome
Association Study of Bipolar Disorder,” n.d.). Out of 653 EA cases in the data set, 2 outliers
were identified by principal component analysis (Price et al., 2006) using the HelixTree software
suite (Golden Helix, Bozeman, MT) and removed. Of these cases, 605 of them carried the BD-I
diagnosis and were evaluated in the current study. This data set also provided 1034 EA controls.
Genotyping data was derived from the Affymetrix 6.0 microarray and included 729,454 SNPs.
The collection of the DNA samples and the associated phenotypic information was described
by Smith and colleagues in a supplement to their report (Smith et al., 2009). Cases were selected
from individuals who had been identified over an 18-year period. The subject accrual was
performed in five successive efforts referred to as “Waves”. The first two Waves involved four
sites and focused on large pedigrees that each contained multiple individuals affected by mental
illness as well as a BD-I proband. Waves 3 and 4 focused on smaller pedigrees and involved 11
sites. Wave 5 mainly included only individual, unrelated cases that were collected for the
purpose of conducting large-scale association studies. The GWAS study performed by Smith
and colleagues selected 175 unrelated EA subjects from Waves 1 and 2, 396 subjects from
Waves 3 and 4, and 430 subjects from Wave 5. Subjects were evaluated using the Diagnostic
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Interview for Genetic Studies tool, which was revised between Waves 4 and 5 in order to
increase the amount of information collected. All indicators were scored by a senior clinician
who was typically a psychiatrist. Of the 1,041 subjects who were initially selected, 40 were
excluded because of uncertainty regarding the diagnosis. Controls were gathered by a separate
process that relied upon a self-administered questionnaire. Individuals were selected as controls
if their questionnaire indicated that they did not suffer from major depression and if they denied
having a history of psychosis or BD.
Data for Controls from a Study of Schizophrenia
A corresponding study of schizophrenia was conducted by the same group of researchers
from whom the BD data were obtained. In order to increase the power of our study, we sought
to include controls from the schizophrenia study in our analysis. These control data were also
obtained via dbGap (phs000021.v3.p2) and are also not subject to approval by an Institutional
Review Board, per the dbGaP website (“dbGaP | phs000021.v3.p2 | Genome-Wide Association
Study of Schizophrenia,” n.d.). Most of the 1442 EA controls from this data set were identical
with control subjects in the BD data set. Consequently, only 362 controls were added to our
study from the schizophrenia study data.
Of the 1,396 controls used in this study, 754 (54.0%) were female and 642 (46.0%) were
male. Of the 605 cases used in this study, 313 (51.7%) were female and 292 (48.3%) were male.

Data Analysis
Association Study Using PLINK
Allelic association analyses (Sasieni, 1997) were performed using PLINK version 1.07
(Purcell, n.d.; Purcell et al., 2007) with the command line “--assoc” flag set.
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Evaluation of Identified Single-Nucleotide Polymorphisms
The quality of the high-scoring SNPs was evaluated in terms of compliance with HardyWeinberg equilibrium (HWE), minor allele frequency (MAF), and genotyping call rate. SNPs
were removed under the following circumstances: HWE p-value < 10-5, MAF < 1%, or call rate
< 95%. A very conservative per test significance level of 7.2 X 10-8 was chosen (Dudbridge &
Gusnanto, 2008). At the same time, we used a less stringent criterion of “suggestive association”
with a cut-off of α = 10-5.
Sequence positions reported in this study refer to Build 36.3 of the human genome sequence.
The relationships between some closely spaced SNPs with respect to linkage disequilibrium were
investigated using the software program Haploview, version 4.2 (Barrett, Fry, Maller, & Daly,
2005). Measures of linkage disequilibrium between SNPs relied upon data available from The
International HapMap Project (“The International HapMap Project,” 2003). The localization of
SNPs to specific regions of chromosomes and to the vicinity of known genes was aided by the
National Center for Bioinformatics (NCBI) through use of a SNP database that is accessible via
the Internet under the moniker dbSNP (“dbSNP Home Page,” n.d.).
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CHAPTER 4
RESULTS
Association Analysis of All Cases
An association analysis of all cases was performed as a point of reference. The results are
shown in Table 1.
This analysis used substantially fewer cases than that of Smith and colleagues (Smith et al.,
2009). Consequently, it was not entirely surprising to see that the significance of the highest
scoring SNPs was lower than that seen in their study. Only 9 SNPs yielded nominal p-values at
or below 10-5, the level at which some researchers consider results to be potentially significant.
SNP rs1825828 was one of the highest-scoring markers detected by Smith and colleagues in their
analysis of the EA subpopulation. When they analyzed the data with the help of a genomic
control method, they obtained a nominal p-value of 2.9 X 10-7 for this SNP, a value that is nearly
10-fold lower than the p-value of 2.49 X 10-6 that was obtainable in this study. This ability of
the current study to detect some of the same markers as the original study in this nonstratified
group of subjects, albeit at a lower level of significance, gives support to the overall validity of
the current analysis and provides a benchmark against which the results obtained from the two
gender strata can be appropriately judged.
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Table 1
SNPs Showing Strongest Association with BD-I, When Testing Against All Cases
______________________________________________________________________________
c
Position
HWE
a
b
d
SNP
Chr
(bp)
MAF
p-value
OR (95% CI)
p-value
______________________________________________________________________________
rs4964010
12
26689656
0.38
0.86
0.69 (0.59-0.80)
1.11 X 10-6
rs12692245

2

239320476

0.42

0.80

1.40 (1.22-1.60)

1.45 X 10-6

rs1825828

3

97873650

0.29

0.0015

0.68 (0.58-0.80)

2.49 X 10-6

rs2893420

1

99736275

0.33

0.20

0.70 (0.60-0.82)

5.70 X 10-6

rs17111920

14

26476732

0.01

0.74

3.07 (1.83-5.14)

7.36 X 10-6

rs10922013

1

194294495

0.25

0.80

0.68 (0.57-0.80)

8.21 X 10-6

rs4128254

2

239310782

0.41

0.86

1.36 (1.19-1.56)

9.06 X 10-6

rs6901039

6

26108864

0.28

0.92

1.39 (1.20-1.61)

9.13 X 10-6

rs1106634

8

20110329

0.12

0.02

1.52 (1.26-1.84)

1.00 X 10-5

rs14380

3

42553583

0.14

0.20

1.48 (1.24-1.76)

1.16 X 10-5

rs12194046

6

113095902

0.10

0.47

1.55 (1.27-1.89)

1.27 X 10-5

rs11585894

1

99744018

0.32

0.08

0.72 (0.61-0.83)

1.42 X 10-5

rs1965290

3

124770496

0.44

0.09

1.35 (1.18-1.55)

1.42 X 10-5

rs1956817

14

26377654

0.005

0.88

3.69 (1.96-6.94)

1.44 X 10-5

rs9458298

6

161884928

0.23

0.69

1.40 (1.20-1.63)

1.51 X 10-5

rs12195005

6

161875995

0.22

0.61

1.40 (1.20-1.64)

1.52 X 10-5

rs802568

7

145590176

0.02

0.01

2.28 (1.55-3.35)

1.55 X 10-5

rs13430905

2

133728463

0.15

0.97

0.62 (0.50-0.78)

1.67 X 10-5

rs8129319

21

19284492

0.18

0.35

0.65 (0.54-0.79)

1.68 X 10-5

rs13388370

2

155345758

0.01

0.79

3.01 (1.78-5.11)

1.73 X 10-5

rs12209107

6

161864009

0.22

0.74

1.40 (1.20-1.63)

1.73 X 10-5

rs1012873

3

180994713

0.05

0.49

1.82 (1.38-2.40)

1.86 X 10-5

rs11239177

10

44443385

0.50

0.32

0.74 (0.65-0.85)

1.88 X 10-5

rs17119815

11

115934773

0.19

0.02

1.43 (1.21-1.69)

1.88 X 10-5

rs7791106
7
78375618
0.12
0.20
0.60 (0.47-0.76)
1.89 X 10-5
______________________________________________________________________________
a
Chr, chromosome number; bMAF, minor allele frequency; cHWE p-value, p-value for test of
Hardy-Weinberg equilibrium; dOR (95% CI), odds ratio and its 95% confidence interval
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Association Analysis of Female Cases
Results from an association analysis of female cases alone are shown in Table 2. This
analysis also demonstrates relatively few higher-scoring SNPs, in this case only 5 SNPs with
p-values less than 10-5.
It should be noted here that the initial output of the association analysis of the female cases
did contain one result that was nominally at a level of high statistical significance. This result
was for SNP rs5932307, which lies on the X chromosome at position 126,993,095 base pairs.
However, the p-value for the test of Hardy-Weinberg equilibrium was, at 3.32 X 10-180, far less
than 10-5 and this was, therefore, regarded to be an invalid result for the purposes of this study
because of the deviation from HWE (Sasieni, 1997). This SNP is in an intergenic region on the
long arm of the X chromosome (Xq25) approximately 19.5 kb downstream from the ACTRT1
gene that encodes an actin-like protein (Heid et al., 2002). This region of the X chromosome
does not correspond to any of those identified in a recent review of the genetics of bipolar
disorder as candidate chromosomal regions for this disorder (Serretti & Mandelli, 2008).
Three other X chromosome SNPs (rs6525223, rs17265313, and rs5965550) were also
considered invalid due to violation of HWE and are not shown in Table 2. The SNPs yielded
p-values ranging between 1.71 X 10-5 and 3.41 X 10-5. All three SNPs lie close to each on the
long arm of the X chromosome (Xq12) in the oligophrenin 1 gene (OPHN1), which encodes a
Rho GTPase-activating protein. Deletion of OPHN1 leads to an X-linked syndrome that causes
mental retardation, thought to be through disruption of its role in maturation of synapses (Nadif
Kasri, Nakano-Kobayashi, Malinow, Li, & Van Aelst, 2009). The Xq12 chromosomal region
has also not been previously associated with a high risk of bipolar disorder.
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Table 2
SNPs Showing Strongest Association with BD-I, When Testing Against Female Cases
______________________________________________________________________________
c
Position
HWE
a
b
d
SNP
Chr
(bp)
MAF
p-value
OR (95% CI)
p-value
______________________________________________________________________________
rs2367911
7
81624156
0.02
0.44
2.98 (1.85-4.82)
3.13 X 10-6
rs7291885

22

17009153

0.05

0.62

2.34 (1.61-3.39)

4.36 X 10-6

rs2931018

18

74610846

0.48

0.55

1.53 (1.27-1.85)

7.25 X 10-6

rs1825828

3

97873650

0.29

0.0015

0.60 (0.47-0.75)

7.98 X 10-6

rs7825634

8

91425419

0.02

0.53

3.28 (1.89-5.70)

8.38 X 10-6

rs1992045

8

59003478

0.06

0.19

2.70 (1.48-2.90)

1.37 X 10-5

rs2373842

7

88589572

0.23

0.69

1.60 (1.29-1.98)

1.41 X 10-5

rs2189061

7

88577308

0.23

0.54

1.59 (1.28-1.97)

1.99 X 10-5

rs6980880

8

123856242

0.44

0.02

0.66 (0.54-0.80)

2.41 X 10-5

rs11986500

8

62113757

0.10

0.96

1.82 (1.38-2.42)

2.53 X 10-5

rs1020605

2

12314886

0.08

0.27

1.87 (1.39-2.51)

2.56 X 10-5

rs16934680

11

17721489

0.17

0.66

1.64 (1.30-2.07)

2.64 X 10-5

rs17152884

8

11018996

0.01

0.72

3.99 (1.99-8.03)

2.82 X 10-5

rs470422

13

105452539

0.25

0.79

1.55 (1.26-1.91)

2.98 X 10-5

rs11651919

17

30090490

0.50

0.80

1.49 (1.23-1.80)

3.17 X 10-5

rs17111920

14

26476732

0.01

0.74

3.95 (1.97-7.95)

3.28 X 10-5

rs1992044

8

59003462

0.06

0.38

1.98 (1.42-2.75)

3.69 X 10-5

rs3852489

10

92769203

0.42

0.60

0.67 (0.55-0.81)

3.87 X 10-5

rs4076005

2

192410652

0.48

0.50

1.49 (1.23-1.80)

3.91 X 10-5

rs4665788

2

21041972

0.25

0.45

1.54 (1.25-1.89)

3.98 X 10-5

rs2167201

4

139749099

0.46

0.01

1.48 (1.23-1.79)

4.04 X 10-5

rs9505426

6

831884

0.04

0.59

2.31 (1.53-3.49)

4.22 X 10-5

rs4142729

2

39076419

0.07

0.17

1.98 (1.42-2.76)

4.81 X 10-5

rs3094356

5

9801246

0.44

0.63

0.67 (0.56-0.82)

4.82 X 10-5

rs6036025
20
21987868
0.08
0.73
1.87 (1.38-2.54)
4.91 X 10-5
______________________________________________________________________________
a
Chr, chromosome number; bMAF, minor allele frequency; cHWE p-value, p-value for test of
Hardy-Weinberg equilibrium; dOR (95% CI), odds ratio and its 95% confidence interval
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Association Analysis of Male Cases
The results for the association analysis of the male cases are shown in Table 3. These results
are strikingly different from those of the analyses that examined all cases or just female cases.
One SNP, rs 6046396, yielded a nominal p-value of 3.91 X 10-9. This appears to be significant
on a per test basis. Also, there are 18 other SNPs with p-values less than 10-5. Most of these
highly significant SNPs are located in regions on chromosomes 6, 8, 14, 15, and 20.
The considerably stronger association results for the male cases is especially interesting,
given that there are only about half the cases here as were evaluated in the “all cases” analysis.
This suggests the possibility of male-specific effects that are masked when both genders are
evaluated together or when females are studied separately.
The highest-scoring SNP, rs 6046396, and the other two SNPs on chromosome 20, rs4813377
and rs4813376, are located in an intergenic region, downstream of the gene SLC24A3 and
upstream of the gene RIN2 (Figure 1). Analysis of the CEU (Northern European ancestry) data
provided by The International HapMap Project using the Haploview software program shows
considerable linkage disequilibrium between the SNPs on chromosome 20 (Figure 2). There are
three high-scoring SNPs in a region of chromosome 14. While the highest-scoring SNP,
rs11158205, lies within an intron of the gene KIAA0586, the other two SNPs, rs7155496 and
rs12587974, are in an intergenic region approximately 100 kb downstream of KIAA0586. The
minor allele of all three of these SNPs on chromosome 14 displayed a modest protective effect
relative to BD. The next highest-scoring SNPs, rs4276463 and rs9343877, are located close to
each other on chromosome 6 in an intergenic region between genes PHIP and HMGN3. There
are also nine SNPs listed in Table 3 that lie on chromosome 15 within the gene LASS3.
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Table 3
SNPs Showing Strongest Association with BD-I, When Testing Against Male Cases
______________________________________________________________________________
c
Position
HWE
a
b
d
SNP
Chr
(bp)
MAF
p-value
OR (95% CI)
p-value
______________________________________________________________________________
rs6046396
20
19800503
0.26
0.46
1.89 (1.52-2.33)
3.91X 10-9
rs11158206

14

58017118

0.31

0.16

0.58 (0.46-0.73)

2.48 X 10-6

rs4276463

6

79937274

0.09

0.55

2.18 (1.57-3.05)

2.71 X 10-6

rs9343877

6

79922723

0.07

0.43

2.31 (1.60-3.31)

3.86 X 10-6

rs2654596

15

98798517

0.27

0.30

1.63 (1.33-2.02)

4.10 X 10-6

rs2587742

15

98752615

0.27

0.19

1.63 (1.32-2.01)

4.14 X 10-6

rs2587784

15

98862970

0.26

0.00

1.66 (1.33-2.05)

4.20 X 10-6

rs2243973

14

85665903

0.05

0.64

2.61 (1.71-4.00)

4.70 X 10-6

rs2587814

15

98788816

0.27

0.22

1.62 (1.31-2.00)

5.83 X 10-6

rs2654642

15

98839754

0.31

0.14

1.60 (1.30-1.96)

6.47 X 10-6

rs7012730

8

135131419

0.03

0.30

3.06 (1.84-5.09)

6.55 X 10-6

rs4813377

20

19799466

0.16

0.89

1.79 (1.39-2.31)

6.56 X 10-6

rs1106634

8

20110329

0.12

0.02

1.85 (1.41-2.42)

7.31 X 10-6

rs7155496

14

58132929

0.36

0.06

0.61 (0.49-0.76)

7.72 X 10-6

rs16905065

8

135146666

0.05

0.96

2.41 (1.62-3.59)

8.56 X 10-6

rs4813376

20

19799455

0.14

0.44

1.80 (1.39-2.34)

9.04 X 10-6

rs17629030

4

171304652

0.05

0.05

2.36 (1.60-3.49)

9.07 X 10-6

rs12587974

14

58120895

0.30

0.08

0.59 (0.47-0.75)

9.75 X 10-6

rs2585243

15

98752202

0.27

0.26

1.60 (1.30-1.98)

9.76 X 10-6

rs1503474

15

98820261

0.33

0.34

1.57 (1.29-1.93)

1.01 X 10-5

rs10503391

8

8692796

0.09

0.50

0.40 (0.26-0.61)

1.03 X 10-5

rs2587741

15

98752634

0.27

0.40

1.60 (1.30-1.97)

1.14 X 10-5

rs17068296

8

3817488

0.02

0.37

3.71 (1.98-6.98)

1.34 X 10-5

rs2587813

15

98790270

0.27

0.17

1.59 (1.29-1.96)

1.42 X 10-5

rs1017706
6
77479216
0.14
0.02
1.80 (1.38-2.36)
1.52 X 10-5
______________________________________________________________________________
a
Chr, chromosome number; bMAF, minor allele frequency; cHWE p-value, p-value for test of
Hardy-Weinberg equilibrium; dOR (95% CI), odds ratio and its 95% confidence interval
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Figure 1. Map Showing the Location of SNP rs6046396 on Human Chromosome 20

Figure 2. Linkage Disequilibrium Structure of SNPs Within a 13-Kilobase Block at 20p11. The
numbers indicate the r2 values between the corresponding pairs of SNPs. The linkage
disequilibrium data derive from the CEU (Northern European ancestry) portion of The
International HapMap Project data.
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CHAPTER 5
DISCUSSION
The identification of the SNP, rs6046396, on chromosome 20 is, by far, the most interesting
finding from this study. Given the origin of the data set being examined here, a key
consideration is to review whether this SNP was observed by Smith and colleagues in their
GWAS study with this data set (Smith et al., 2009). They did, in fact, detect this SNP in a
portion of their analysis. It yielded a nominal p-value of 4.93 X 10-7 in a side analysis performed
on a subset of their data that they referred to as the “Pritzker non-overlap data set”. They derived
this data set by removing a portion of their data, the part that had been obtained from the Pritzker
Neuropsychiatric Disorders Research Consortium. Interestingly, this SNP did not score as well
when the entire data set was examined by Smith and colleagues and became more significant
only when they evaluated the smaller “Pritzker non-overlap data set”. Significantly, that
corresponds to the situation in the current study. This SNP only became significant when a
portion of the data (the male cases) were examined in the current study. This SNP was also
observed with a p-value of 8.62 X 10-5 by Wang and colleagues (Wang, Liu, & Aragam, 2010)
when they performed a genome-wide meta-analysis with the same data set used here in
combination with corresponding data obtained from schizophrenia patients.
A careful review of the literature suggests that the presence of this susceptibility locus for BD
on the short arm of chromosome 20 has been detected several times before in linkage scans.
Detera-Wadleigh and colleagues detected a signal (p=0.05) at D20S0604 in a study of 97 NIMH
pedigrees (Detera-Wadleigh et al., 1997). Radhakrishna and colleagues studied a large Turkish
pedigree with apparently dominant BD and located evidence of a susceptibility locus on
chromosome 20, based on markers D20S604, D20S470, D20S836, and D20S838, with the
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highest 2-point LOD score being 4.34 (Radhakrishna et al., 2001). Haplotype analysis placed the
BD locus between the microsatellite markers D20S186 and D20S109. A replication set of 56
NIMH pedigrees that was evaluated by Willour and colleagues confirmed the locus on
chromosome 20 with a peak between markers D20S162 and D20S604 (Willour et al., 2003).
Very recently, Oedegaard and colleagues performed a genome-wide linkage analysis of BD and
comorbid migraine (Oedegaard, Greenwood, Lunde, et al., 2010). They detected a region of the
short arm of chromosome 20 where susceptibility to BD and migraine seemed to be coincident,
with a peak at approximately 49 cM (about 19 Mb).
The three high-scoring SNPs on chromosome 20 that were detected in this study are in an
intergenic region between RIN2 and SLC24A3. Because they lie upstream of RIN2, one might
expect that they are in an area related to the control of transcription of RIN2 and that RIN2 is the
gene involved in BD at this locus. However, a consideration of what is known about these two
genes may be worthwhile in assessing which gene is, in fact, involved in BD. The RIN2 protein
has been found to interact with the GTPase Rab5 (Saito et al., 2002). The Rab GTPases serve as
regulators of endocytosis, and the disruption of their normal function has been implicated in a
number of disease processes. However, RIN2 is expressed at relatively low levels in the brain
and the only central nervous disease with which Rab5 has been associated is Alzheimer’s disease
(Agola, Jim, Ward, Basuray, & Wandinger-Ness, 2011). Furthermore, deficiency of RIN2 has
been found to result in a syndrome typified by macrocephaly, alopecia, cutis laxa, and scoliosis
(Basel-Vanagaite et al., 2009; Syx et al., 2010). Thus, based on several lines of evidence, RIN2
does not seem a very likely candidate for the genetic effect associated with these SNPs.
However, Schubert and colleagues have recently published a review of evidence that implicates
dysfunction of clathrin-coated vesicles in the pathogenesis of BD and schizophrenia (Schubert,
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Föcking, Prehn, & Cotter, 2011). Because Rab5 is a key control component of this pathway, the
RIN2 gene product is, likewise, possibly involved via its action on Rab5. There is a need for
more experimental work to cement this still tenuous connection. In contrast to this, SLC24A3 is
a more appealing prospect. It is a potassium-dependent sodium/calcium exchanger found at high
levels in the neurons of the thalamus, the hippocampal CA1 area, and layer IV of the cerebral
cortex (Altimimi & Schnetkamp, 2007; Kraev et al., 2001). Ion channels of this type also play
important roles in controlling vascular tone through actions on smooth muscle cells in vessel
walls and may, therefore, be involved in migraine headaches that have a vascular origin. As
noted earlier, there is evidence that ion channels are likely very important to the pathophysiology
of BD. Together, these features of SLC24A3 seem to make it a somewhat better BD gene
candidate than RIN2. A more definitive assessment of the role of SLC24A3 will require further
evaluation of the genetic variation at this locus and the relationship of that variation to the
occurrence of BD.
This study has yielded initial support for the hypothesis that some of the effects of the genetic
variation underlying BD are modified by gender. The approach described here is novel to the
study of BD and has proven worthwhile in its ability to detect a potential disease locus that has
been implicated by earlier linkage and association studies and that is biologically plausible. The
plausibility of there being a locus predisposing to BD in the vicinity of rs6046396 is supported
most strongly by the independent discovery of two nearby, highly significant SNPs with
moderately strong linkage to rs6046396. Their detection and independence from rs6046396
greatly lowers the probability that the detection of rs6046396 is spurious. The presence of two
reasonable gene candidates flanking rs6046396, either of which could be mechanistically
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associated with BD, provides additional support for the validity of the detection of rs6046396 as
an important marker for susceptibility to BD.
While these results regarding rs6046396 are potentially significant, it should be borne in mind
that this marker has only been detected, both in this study and two earlier ones (Smith et al.,
2009; Wang et al., 2010), in subjects taken from the same data set. The data set that was
analyzed in the current study, as is the case with many genetic studies of mental illness, is
complex and represents the contributions of materials and information from many institutions
over a period of nearly 2 decades. Consequently, this data set may contain errors and/or biases
that might lead to erroneous conclusions. Therefore, in order to reach a higher level of
confidence regarding the true importance of the locus detected by rs6046396, this result will
need to be replicated in other studies that evaluate a different group of subjects.
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